Life Science Leader Blogs

  1. Did BIO 2018 Do More Than Make History In Boston?

    BIO 2018 does more than make business meeting history, but facilitates personal connections that can lead toward doing better business.

  2. BIO 2018 — A View Through The Eyes Of An Aspiring Biomedical Engineer

    Miriam Massaad, a biomedical engineering student at Boston University, shares her experiences as a first-time attendee at the 2018 BIO International Convention and Conference in Boston.

  3. What Is MassBio Doing To Promote Greater Diversity And Inclusion?

    Robert Coughlin, president and CEO of MassBio, discusses his organization’s approach to diversity and inclusion.

  4. Research Into The State Of Innovation In Highly Prevalent Chronic Diseases

    Dave Thomas, managing director for industry research and analysis at the Biotechnology Innovation Organization (BIO), discusses chronic disease research and other industry trends.

  5. The Scientist Mentoring And Diversity Program — An Inside View From A Current Scholar

    Shaness Grenald, Ph.D., a postdoctoral fellow in the department of anesthesiology and critical care medicine at Johns Hopkins University, discusses the Scientist Mentoring and Diversity Program (SMDP) at the 2018 BIO Buzz Center in Boston. 

  6. Are You Ready For BIO 2018 In Boston?

    Tips to help you get ready for the 2018 BIO International Convention in Boston, June 4 - 7.

  7. Is The Open Office Concept An Idea That Should Have Been Killed?

    Rob Wright discusses the open office concept, and if it is an idea that should be killed.

  8. A Testament To Biopharma’s Transparent Leaders: And A Previously Unpublished Regeneron Article Sidebar

    Rob Wright discusses the unusual genesis of the Regeneron Genetics Center (RGC).

  9. 4 Can’t-Miss Educational Sessions At BIO 2018

    Rob Wright lists four can’t miss educational sessions for this year’s annual BIO International Convention in Boston.

  10. My 10 Favorite Quotes From George Yancopoulos

    My 10 favorite quotes from interviewing George Yancopoulos, M.D., Ph.D., president and chief scientific officer at Regeneron Pharmaceuticals.